Considerations about the ethical, sustainable, affordable effects of health care transformation come through clearly in Philips’ ninth Future Health Index global survey of 2,800 health care leaders. The quantitative and qualitative survey was compiled in 2023-24.

The collective responses paint a picture of an industry transitioning concertedly to AI-enabled care yet reflect residual concerns among pockets of clinicians and physicians whose key demand is: “Show me the impact and the outcomes” on patients and finances.

Philips views FHI as a tool for discussions with health care stakeholders and clients, bearing in mind the 2024 findings showing health care leaders’ prime concerns about:

Potential burnout, stress and mental issues among staff (two thirds of health care leaders agreed on this)
Patients travelling too far for necessary care (50%)
Staff spending too much time integrating data results rather than caring for patients
Financial challenges that are limiting resources and lengthening waiting times, resulting in treatments being offered more selectively (81%) and/or hampering scope to invest in new technology (59%).

Health care leaders see better care being delivered through data, specifically identifying its potential for:

Optimizing care pathways (43%), implementing evidence-based practice (37%) and reducing waiting lists for diagnostic and elective procedures (36%).

AI in remote patient monitoring is an area of focus for the next three years as health care leaders increasingly focus on expanding care beyond the hospital’s walls. In the meantime, around 70% of health care leaders say AI is already being used for clinical decision support (CDS) – or will be in the next three years – for:

Remote and inpatient monitoring
Preventive care
Pathology
Radiology
Treatment planning, medication management and “clinical command centers.”

Clinicians: ‘Show Me The Impact And Outcomes Of AI Tools’

Health Sector Leaders Are Gaining Increased Awareness Of AI’s Role In Bridging The Gaps To Sustainable Health Care

More from Leadership

More from Medtech Insight